cilostazol has been researched along with Liver Cirrhosis in 3 studies
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvacrol is a natural phenolic monoterpenoid, and cilostazol is a selective phosphodiesterase-3 inhibitor with antioxidant, anti-inflammatory and antiapoptotic effects." | 1.91 | Combined carvacrol and cilostazol ameliorate ethanol-induced liver fibrosis in rats: Possible role of SIRT1/Nrf2/HO-1 pathway. ( Abu-Risha, SE; Elbohoty, HR; Elsisi, AE; Sokar, SS, 2023) |
| "Induction of liver fibrosis in TAA-treated rats was observed as evidenced by the biochemical and histopathological findings." | 1.51 | Regression of fibrosis by cilostazol in a rat model of thioacetamide-induced liver fibrosis: Up regulation of hepatic cAMP, and modulation of inflammatory, oxidative stress and apoptotic biomarkers. ( Abdel Rahman, RF; Arbid, MS; Badawi, M; El Awdan, SA; El Marasy, SA; Hegazy, RR; Ibrahim, HM, 2019) |
| "Cilostazol is a phosphodiesterase III inhibitor increases adenosine 3', 5'-cyclic monophosphate (cyclic AMP) level which inhibits hepatic stellate cell activation." | 1.42 | Cilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats. ( Abdel Kawy, HS, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Risha, SE | 1 |
| Sokar, SS | 1 |
| Elbohoty, HR | 1 |
| Elsisi, AE | 1 |
| El Awdan, SA | 1 |
| Abdel Rahman, RF | 1 |
| Ibrahim, HM | 1 |
| Hegazy, RR | 1 |
| El Marasy, SA | 1 |
| Badawi, M | 1 |
| Arbid, MS | 1 |
| Abdel Kawy, HS | 1 |
3 other studies available for cilostazol and Liver Cirrhosis
| Article | Year |
|---|---|
Combined carvacrol and cilostazol ameliorate ethanol-induced liver fibrosis in rats: Possible role of SIRT1/Nrf2/HO-1 pathway.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cilostazol; Cytokines; Ethanol; Liver; Liver Cirrho | 2023 |
Regression of fibrosis by cilostazol in a rat model of thioacetamide-induced liver fibrosis: Up regulation of hepatic cAMP, and modulation of inflammatory, oxidative stress and apoptotic biomarkers.
Topics: Animals; Apoptosis; Biomarkers; Cilostazol; Cyclic AMP; Inflammation; Liver; Liver Cirrhosis; Oxidat | 2019 |
Cilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats.
Topics: Actins; Animals; Cholestasis; Cilostazol; Common Bile Duct; Dose-Response Relationship, Drug; Hemogl | 2015 |